AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,529 Cr |
| Mar2024 | ₹2,716 Cr |
| Mar2023 | ₹2,489 Cr |
| Mar2022 | ₹2,155 Cr |
| Mar2021 | ₹1,806 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,529 Cr | -6.90 | |
| Mar2024 | ₹2,716 Cr | 9.14 | |
| Mar2023 | ₹2,489 Cr | 15.49 | |
| Mar2022 | ₹2,155 Cr | 19.31 | |
| Mar2021 | ₹1,806 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,359.8 Cr | -0.9% | -3% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.9% |
-3% |
-20.4% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses